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The first results of the ENCODE (Encyclopedia of DNA Elements) project have 
been recently presented in 30 articles published in Nature, Genome Research and 
Genome Biology (see for example the article published in Nature 489, pp 57–74, 
by the ENCODE Project Consortium, related articles in the same issue of Nature 
and references therein). These articles present the results obtained by the 
collaborative work of 32 research groups and more than 440 scientists during the 
last 5 years. The ENCODE project arose as a consequence of the human genome 
sequence published 11 years ago. Analyses of the human DNA genome showed 
that only 1.2 % of the nucleotides coded for about 20,000 proteins present in our 
organism and opened the intriguing question of what is the function of the 
remaining 98.8 % of the DNA. The ENCODE project was aimed to answer this 
fundamental question and now reports the biochemical function for 80 % of the 
genome. It is remarkable that most of the regions characterized participate in the 
regulation of gene expression that is central to embryonic development, cell 
differentiation, cellular homeostasis and physiopathological processes. 
 
One of the objectives of the ENCODE project was to identify all the RNA molecules 
transcribed from the DNA and to determine all the transcription initiation sites. 
Surprisingly, about 60 % of the genome is transcribed into RNA, including intron 
and intergenic regions. Many DNA  regions are transcribed from both strands, 
originating different RNA molecules. These studies have allowed the discovery of 
new classes of RNA molecules, which mainl participate in the regulation of gene 
expression. The project has also analysed the structure of the chromatin and the 
DNA-binding site of a large number of proteins involved in the regulation of 
chromatin structure and gene expression, such as different histone isoforms, 
modified histones (acetylated or methylated), components of the RNA polymerase 
complex and transcription factors. These studies were based on the use of  
genome-wide chromatin immunoprecipitation methods. The use of massive 
sequencing techniques has also been crucial for the identification of 
different RNA molecules, chromatin structures and protein-binding sites. All these 
different techniques were initially applied on a region of 1 % of the genome, in a 
pilot project, and scaled up to the rest of the genome from 2007. Gene regulation is 
specific to each of the thousands of cell types present in our organism so that 
these studies were made in 147 cell types to cope with some of this diversity. 
There is also considerable diversity in the number of chromatin modifications and 
transcription factors that operate in the different cell types. Therefore, 13 
chromatinassociated variations, 14 RNA polymerase and basal-transcription 
factors and 87 sequence-specific transcription factors were analysed, in addition to 
DNA methylation and DNase I hypersensitive sites. In total, 1,640 genome-wide 
data sets were prepared and analysed in the project.  
 
The results obtained in the ENCODE project offer a new perspective on the 
structure and function of the genome. It becomes clear that a very significant part 
of the genome is transcribed and that most of this transcription is related to gene 
expression regulation. The project has also provided an estimate number of the 
variants generated for each protein-coding gene, on average 6.3 alternatively 
spliced transcripts per locus. Mapping of transcription start sites has identified 
62,403 sites, about 44 % of them are close to the 50 end of messenger RNAs but 
the rest might correspond to the start site of novel types of RNA. The data obtained 
on DNA methylation, DNase I sensitivity and protein-binding studies have  
generated a huge amount of  information on the mechanisms of gene expression 
regulation. Thousands of regulatory regions, including enhancer regions, have 
been identified. Comparison of the determined protein-binding and chromatin-
structure patterns allowed the identification of molecular signatures characteristic 
for different regulatory and structural elements. Integration of the multiple data has 
been used for the development of predictive models of gene expression. Actually, 
this accumulation of genome-wide information is changing our view of gene 
transcription regulation. 
 
A very important implication of the ENCODE project is that now it is possible to 
assign a function to many regions of the genome that were previously completely 
unknown. The relevance of this change is shown by the fact that many nucleotide 
polymorphisms or small insertions and deletions related to diseases or disease 
predisposition map to previously uncharacterized intergenic regions. This has been 
an important constrain in the many genome-wide association studies (GWAS) 
carried out in the last years, trying to link DNA sequences variations with specific 
traits and diseases. The information provided by the ENCODE project makes now 
possible to assign a function to many of the polymorphisms identified in non 
protein-coding regions of the genome which will surely have a large impact on the 
prognosis and diagnosis of these diseases and might even open the way to new 
therapeutic strategies. 
 
The new genome landscape offered by the project can also affect the design of 
new studies on the genetics bases of hereditary diseases or cancer. Because of 
technical and economic reasons, many of the studies presently made are focused 
on the sequencing of the protein-coding regions of the genome, the exome or the 
transcriptome. However, GWAS studies have shown that almost 90 % of the 
associated variants fall outside protein-coding genes and would not be detected in 
many of the present studies. The availability of cheaper deep-sequencing methods, 
together with the functional annotation of many genome regions provided by the 
ENCODE project, will probably contribute to a significant increase of genome-wide 
studies in cancer and hereditary traits and diseases that can provide an extensive 
view of all the possible nucleotide polymorphisms involved in these pathologic 
processes. 
 
The data generated by the ENCODE project are public and can be explored on line 
through a visualization tool designed by the Nature scientific journal (http://www. 
nature.com/ENCODE). 
 
